Phase 3 dose selection for selinexor in TP53wt endometrial cancer based on exposure-response analysis Meeting Abstract
| Authors: | Makker, V.; Richardson, D. L.; Chon, H. S.; Miller, D. S.; Mau-Sorensen, M.; Cibula, D.; Zagouri, F.; Fidalgo, A. P.; Slomovitz, B. M.; Coleman, R. L.; Kalyanapu, P.; Fan, R.; Gudi, G.; Vergote, I. |
| Abstract Title: | Phase 3 dose selection for selinexor in TP53wt endometrial cancer based on exposure-response analysis |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401439 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.5594 |
| Notes: | Meeting Abstract: 5594 -- Source: Wos |
